Immunoassay For Detection Of Amniotic Fluid Protein(S).
NQM is the FDA product code for Immunoassay For Detection Of Amniotic Fluid Protein(S)., a class I device type, regulated under 21 CFR 862.1550. FDA's definition for this code reads: "The test is for use by health care professionals to aid in the detection of fetal membrane rupture in pregnant women, when they report signs, symptoms or complaints suggestive of such rupture". As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and 3 recalls.
Classification record
- Product code
- NQM
- Device name
- Immunoassay For Detection Of Amniotic Fluid Protein(S).
- FDA definition
- The test is for use by health care professionals to aid in the detection of fetal membrane rupture in pregnant women, when they report signs, symptoms or complaints suggestive of such rupture.
- Regulation
- 21 CFR 862.1550
- Device class
- Class I
- Review panel
- Clinical Chemistry
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 2
- Ingested recalls
- 3
Clearances, product code NQM
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
Applicants with the most clearances
Product code NQM| Applicant | Clearances |
|---|---|
| Amnisure International, LLC | 1 |
| Clinical Innovations, LLC | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
